Array BioPharma to Present at the Roth Capital Partners 2006 New York Conference

    BOULDER, Colo., Aug. 28 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
 (Nasdaq:   ARRY) today announced that its Chief Executive Officer, Robert E.
 Conway, will speak at the Roth Capital Partners 2006 New York Conference on
 September 6 in New York City. The public is welcome to participate in the
 conference through an audio webcast on the Array BioPharma website.
     Event:          The Roth Capital Partners 2006 New York Conference
     Presenter:      Robert E. Conway, Chief Executive Officer, Array BioPharma
     Date:           Wednesday, September 6, 2006
     Time:           4:00 pm Eastern Time
     Location:       The Westin New York at Times Square, New York City
     Audio Webcast:  www.arraybiopharma.com
 
     About Array BioPharma:
     Array BioPharma Inc. is a biopharmaceutical company focused on the
 discovery, development and commercialization of targeted small molecule
 drugs to treat life threatening and debilitating diseases. Our proprietary
 drug development pipeline is focused on the treatment of cancer and
 inflammatory disease and includes clinical candidates that are designed to
 regulate therapeutically important targets. In addition, leading
 pharmaceutical and biotechnology companies collaborate with Array to
 discover and develop drug candidates across a broad range of therapeutic
 areas. For more information on Array, please go to www.arraybiopharma.com.
 
 

SOURCE Array BioPharma Inc.